# Double-blind Randomized Controlled Trial Comparing Suvorexant 20 mg to Placebo for Treatment of Insomnia in Cancer Survivors

> **NCT06162663** · PHASE4 · TERMINATED · sponsor: **Medical University of South Carolina** · enrollment: 5 (actual)

## Conditions studied

- Breast Cancer
- Insomnia

## Interventions

- **DRUG:** Suvorexant Tablets
- **OTHER:** Placebo Control

## Key facts

- **NCT ID:** NCT06162663
- **Lead sponsor:** Medical University of South Carolina
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2024-09-20
- **Primary completion:** 2026-02-17
- **Final completion:** 2026-02-17
- **Target enrollment:** 5 (ACTUAL)
- **Why stopped:** Failure to reach study enrollment milestones
- **Last updated:** 2026-02-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06162663

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06162663, "Double-blind Randomized Controlled Trial Comparing Suvorexant 20 mg to Placebo for Treatment of Insomnia in Cancer Survivors". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06162663. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*